Converging evidence implicates dysregulation of the catecholaminergic circuits in the pathophysiology of ADHD with molecular imaging studies suggesting impaired neurotransmission due to abnormalities in the dopamine transporter (Doyle et al., 2005). This evidence concerns the gene SLC6A3 and attention deficit-hyperactivity disorder.